When:
Tuesday, Apr 16, 2019 8:00a -
Thursday, Apr 18, 2019 5:00p

Where:
Hyatt Regency Boston
1 Avenue de Lafayette
Boston, MA 02111

Admission:
$4097.0

Categories:
Lectures & Conferences

Event website:
https://go.evvnt.com/330936-0?pid=5248

Collaborate with your peers at the Neuroimmunology Drug Development Summit (NIDD), the first industry-focused networking forum to learn and share insight on how to successfully target chronic neuroinflammation as a universal therapeutic for various neurological diseases.

With an emphasis on neurodegeneration, NIDD will provide a discussion-led platform for you to discover the best strategies and most innovative technologies to aid your future neuroimmunological research.

Join the 70+ world class experts from AbbVie, Sanofi, Denali, Alector and Eisai to successfully guide the development of clinically efficacious therapeutics.

URLs:
Tickets https://go.evvnt.com/330936-2?pid=5248
Brochure https://go.evvnt.com/330936-3?pid=5248

Prices:
Conference + 2 Workshops: USD 4097.0,
Early Bird Price: USD 3897.0,
Conference + 1 Workshop: USD 3498.0,
Early Bird Price: USD 3298.0

Speakers: Sally Ishizaka (Eisai), Richard Ransohoff (Third Rock Ventures), Thomas Misko (AbbVie), Tarek Samad (Sanofi), Robert Nelson (MindImmune Therapeutics), Ajay Verma (United Neuroscience)

Share this event

Add to:

16/04/2019 08:00:00 18/04/2019 17:00:00 15 Neuroimmunology Drug Development Summit, NIDD Collaborate with your peers at the Neuroimmunology Drug Development Summit (NIDD), the first industry-focused networking forum to learn and share insight on how to successfully target chronic neuro... Hyatt Regency Boston, Boston, MA 02111 Organizer Organizer e-mail false DD/MM/YYYY Reddit